🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ameloblastoma is the most common benign odontogenic tumor, characterized by...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-03-01
Trial ID
NCT06819605
Treatments Being Tested
This research study is studying a combination of drugs as a possible treatm...
Status
Unknown
Location
Massachusetts General Hosital Cancer Center
Start Date
2018-10-15
Trial ID
NCT03668431
Treatments Being Tested
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
This study is being done to find out if the combination of dabrafenib, tram...
Status
Withdrawn
Location
University of Texas Southwestern Medical Center
Start Date
2016-10
Trial ID
NCT02915666
Treatments Being Tested
Erdheim-Chester Diseases (ECD) is a very rare non-Langerhans cell histiocyt...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2014-11-01
Trial ID
NCT02281760
Treatments Being Tested
This is a prospective non-randomized national clinical phase 2 trial that a...
Status
Recruiting
Location
Turku University Hospital Cancer Centre
Start Date
2021-12-10
Trial ID
NCT05159245
This clinical trial is to clarify whether treatment with a checkpoint inhib...
Status
Recruiting
Location
Herlev Universityhospital
Start Date
2018-06-06
Trial ID
NCT03563729
This is a global, multi-centre, open-label, study of GSK2118436 conducted i...
Status
Terminated
Location
GSK Investigational Site
Start Date
2014-04-08
Trial ID
NCT01978236
Treatments Being Tested
The purpose of this study is to find out whether a drug called PDR001, comb...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2020-09-02
Trial ID
NCT04544111
Treatments Being Tested
IMPRESS-Norway is a prospective, non-randomized clinical trial evaluating e...
Status
Recruiting
Location
Sykehuset Ålesund
Start Date
2021-04-01
Trial ID
NCT04817956
Treatments Being Tested